Moleculin Biotech faces critical funding test as Annamycin’s 43% leukemia remission rate advances toward pivotal readout
PulseAI wins FDA clearance for smartwatch ECG analysis after study shows 92% fewer inconclusive results
Read More Pharma Industry News Technology News What clinicians may watch next in Evaxion A/S’s artificial intelligence vaccine platform What clinicians and investors may watch next in Evaxion A/S’s AI vaccine platform as polio and CMV programs test the commercial case for TechBio innovation. bySoujanya RaviApril 2, 2026